DK285589A - Anvendelse af oxochinazolinderivater til fremstilling af et laegemiddel mod hyperlipidaemi - Google Patents
Anvendelse af oxochinazolinderivater til fremstilling af et laegemiddel mod hyperlipidaemi Download PDFInfo
- Publication number
- DK285589A DK285589A DK285589A DK285589A DK285589A DK 285589 A DK285589 A DK 285589A DK 285589 A DK285589 A DK 285589A DK 285589 A DK285589 A DK 285589A DK 285589 A DK285589 A DK 285589A
- Authority
- DK
- Denmark
- Prior art keywords
- oxochinazoline
- hyperlipidaemia
- derivatives
- preparation
- medicine against
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873734909 DE3734909A1 (de) | 1987-10-15 | 1987-10-15 | Verwendung von oxochinazolinderivaten bei der behandlung der hyperlipidaemie |
| PCT/EP1988/000918 WO1989003215A1 (en) | 1987-10-15 | 1988-10-12 | Use of oxoquinazoline derivatives for the treatment of hyperlipidemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK285589A true DK285589A (da) | 1989-06-12 |
| DK285589D0 DK285589D0 (da) | 1989-06-12 |
Family
ID=6338388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK285589A DK285589D0 (da) | 1987-10-15 | 1989-06-12 | Anvendelse af oxochinazolinderivater til fremstilling af et laegemiddel mod hyperlipidaemi |
Country Status (7)
| Country | Link |
|---|---|
| EP (2) | EP0346408A1 (da) |
| JP (1) | JPH01132520A (da) |
| KR (1) | KR890701106A (da) |
| DE (1) | DE3734909A1 (da) |
| DK (1) | DK285589D0 (da) |
| HU (1) | HUT53289A (da) |
| WO (1) | WO1989003215A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0564397A1 (en) * | 1992-03-03 | 1993-10-06 | Sandoz Ltd. | Antiatherosclerotic substituted phenylquinazoline derivatives |
| WO2022122682A2 (de) * | 2020-12-10 | 2022-06-16 | Merck Patent Gmbh | Materialien für organische elektrolumineszenzvorrichtungen |
-
1987
- 1987-10-15 DE DE19873734909 patent/DE3734909A1/de not_active Withdrawn
-
1988
- 1988-10-12 EP EP88909323A patent/EP0346408A1/de not_active Withdrawn
- 1988-10-12 WO PCT/EP1988/000918 patent/WO1989003215A1/de not_active Application Discontinuation
- 1988-10-12 HU HU886315A patent/HUT53289A/hu unknown
- 1988-10-14 JP JP63259270A patent/JPH01132520A/ja active Pending
- 1988-10-14 EP EP88117087A patent/EP0312076B1/de not_active Expired - Lifetime
-
1989
- 1989-06-12 DK DK285589A patent/DK285589D0/da not_active Application Discontinuation
- 1989-06-15 KR KR1019890701083A patent/KR890701106A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0312076B1 (de) | 1991-09-25 |
| EP0346408A1 (de) | 1989-12-20 |
| HU886315D0 (en) | 1990-09-28 |
| JPH01132520A (ja) | 1989-05-25 |
| KR890701106A (ko) | 1989-12-19 |
| DK285589D0 (da) | 1989-06-12 |
| EP0312076A1 (de) | 1989-04-19 |
| DE3734909A1 (de) | 1989-04-27 |
| WO1989003215A1 (en) | 1989-04-20 |
| HUT53289A (en) | 1990-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK156376C (da) | Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug | |
| DK195690A (da) | Anvendelse af coumarinderivater til fremstilling af et laegemiddel mod human immundefekt-virus | |
| DE10075034I1 (de) | Insulinderivate | |
| DK407588A (da) | Oxadiazolforbindelse, farmaceutisk praeparat indeholdende en saadan forbindelse, anvendelse af forbindelsen til fremstilling af et laegemiddel samt fremgangsmaade til fremstilling af en saadan forbindelse | |
| NO891906L (no) | Fremgangsmaate for fremstilling av et harpiksadsorbat av ranitidin. | |
| DK158770C (da) | Anvendelse af paroxetin til fremstilling af medikament mod fedme | |
| FI881882A (fi) | Välineistö hammasproteesin kiinnittämiseksi | |
| NO170079C (no) | Fremgangsmaate for fremstilling av et krystallinsk torasemid | |
| DK349387A (da) | Nitrofuranderivater samt fremgangsmaade til fremstilling deraf og anvendelse af forbindelserne som laegemiddel | |
| DK160739C (da) | Fremgangsmaade til fremstilling af et stabilt prostaglandinindeholdende praeparat til laegemiddelanvendelse | |
| PT91631A (pt) | A process for the preparation of cyclic graf-analogs ii | |
| DK615988A (da) | Fremgangsmaade til fremstilling af et afsvovlingsmiddel | |
| DK645788A (da) | Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat | |
| DK128589A (da) | Anvendelse af piperidinmethanolderivater til fremstilling af et farmaceutisk praeparat | |
| NO870866D0 (no) | Fremgangsmaate for fremstilling av et terapeutisk kombinasjonspreparat. | |
| DK689188D0 (da) | Anvendelse af piperidin-derivater til fremstilling af et farmaceutisk praeparat | |
| DK95489D0 (da) | Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel | |
| DK473088A (da) | Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel | |
| DK473288D0 (da) | Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel | |
| NO171581C (no) | Fremgangsmaate for fremstilling av et soppsmaksmiddel | |
| DK285589A (da) | Anvendelse af oxochinazolinderivater til fremstilling af et laegemiddel mod hyperlipidaemi | |
| DK265789A (da) | Fremstilling af et farmaceutisk praeparat | |
| DK651588A (da) | Anvendelse af en forbindelse til fremstilling af et farmaceutisk praeparat til behandling af fibromyalgia | |
| DK341188A (da) | Fremgangsmaade til fremstilling af en vaeskeabsorberende pude | |
| DK302887A (da) | Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |